Company / Interest Expense
Biogen Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$267.5M
FY2025
5-year range
$246.6M / $267.5M
FY2021-FY2025
Trend
+6.9%
vs FY2024
Sector context
#8 of 42
Health Care
What the data says
Biogen's interest expense of $268M is higher than 81% of companies in the Health Care sector (FY2025). Interest Expense has increased for 3 consecutive years, from $247M in FY2022 to $268M in FY2025.
Based on SEC 10-K filings.
$268M in FY2025 with a 5-year CAGR of +3.8%. Top quartile in the Health Care sector.
Increased from $247M to $268M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +2.7%
- 5-Year CAGR
- +3.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 42This company $267.5M Sector average $305.3M
▼
-12.4% below sector average
Key checks
Key Insights
- Biogen's interest expense has grown for 3 consecutive years.
- 5-year CAGR of +3.8%, indicating consistent growth.
- In FY2025, interest expense increased 6.9% year-over-year.
- Ranks #8 out of 42 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $267.5M | +6.9% |
| FY2024 | $250.3M | +1.4% |
| FY2023 | $246.9M | +0.1% |
| FY2022 | $246.6M | -2.8% |
| FY2021 | $253.6M | +14.0% |
| FY2020 | $222.5M | +18.7% |
| FY2019 | $187.4M | -6.6% |
| FY2018 | $200.6M | -20.0% |
| FY2017 | $250.8M | -3.5% |
| FY2016 | $260.0M | +172.3% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026